Atossa Genetics (ATOS) Reports Q2 Loss of $0.11

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.11), versus ($0.13) reported last year. Revenue for the quarter came in at $2.69 million versus the consensus estimate of $9.9 thousand.

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral